Press Release: MEI Pharma : MEI Pharma Reports Second Quarter Fiscal Year 2025 Cash Position
Evaluation of Strategic Alternatives is Ongoing SAN DIEGO--(BUSINESS WIRE)-- MEI Pharma, Inc. (Nasdaq: MEIP) (the Company) today reported results for its quarter ended December 31,...
Read full article »
MEI Pharma is a California-based clinical-stage pharmaceutical company that researches and develops novel therapeutics for the treatment of cancer.
Read more